Company Information

  

Address: 81 HARTWELL AVE.
SUITE 100 
City: LEXINGTON 
State: MA 
Zip Code: 02421 
Telephone: 646-522-8445 

Description of Business

Primary SIC Code: 2836
(As filed with the SEC)  

Nightstar Therapeutics plc is a public limited company, originally incorporated in England and Wales in July 2017 as a private company with limited liability called Nightstar Therapeutics Limited. NightstaRx Limited was originally incorporated under the laws of England and Wales in May 2013 and changed its name to NightstaRx Limited in January 2014. On September 11, 2017, all shareholders of NightstaRx Limited exchanged each of the different classes of ordinary shares held by them for the same number and class of newly issued ordinary shares of Nightstar Therapeutics Limited and, as a result, NightstaRx Limited became a wholly owned subsidiary of Nightstar Therapeutics Limited on that date. On September 15, 2017, Nightstar Therapeutics Limited re-registered as a public limited company and was renamed Nightstar Therapeutics plc.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
12/2017-1.63NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.16Total Liab/Total Assets0.07
Net Inc/Total Assets-0.22Total Liab/Inv Cap0.07
Net Inc/Inv Cap-0.24Total Liab/Comm Equity0.05
Pretax Inc/Net SalesNAInterest Coverage RatioNA
Net Inc/Net SalesNACurr Debt/EquityNA
Cash Flow/Net SalesNALTD/EquityNA
SG&A/NetSalesNATotal Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio14.37
Inventory TurnoverNACurrent Ratio14.37
Inventory Day SalesNANet Rec/Curr AssetsNA
Net Sales/Work CapNAInv/Curr AssetsNA
Net Sales/PP&ENA  

Income Statement (Millions)

  12/31/2017 6/30/2017 12/31/2016 12/31/2015
Total Revenues(Net Sales) NA NA NA NA
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 7.00 1.41 2.06 2.15
Operating Income -27.50 -7.70 -12.22 -9.32
Interest Exp NA NA NA NA
Pretax Income -29.65 -7.69 -12.20 -13.65
Other Income -2.15 0.01 0.02 -4.32
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -29.69 -7.69 -12.20 -13.65

Balance Sheet (Millions)

Assets 12/31/2017 6/30/2017 12/31/2016 12/31/2015
Cash & Short Term Investments 129.40 69.58 10.12 10.68
Receivables - Total NA NA NA NA
Inventories - Total NA NA NA NA
Total Current Assets 134.84 76.10 14.23 13.82
Net Property, Plant & Equipment 0.36 0.34 0.36 0.25
Total Assets 135.20 76.44 14.60 14.07
Liabilities        
Accounts Payable 9.39 9.72 5.55 2.97
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 9.39 9.72 5.55 2.97
Long-Term Debt NA NA NA NA
Total Liabilities 9.39 9.72 5.55 2.97
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.00 0.00 0.00 0.00
Retained Earnings -62.02 -40.03 -32.34 -20.14
Treasury Stock NA NA NA NA
Total Stockholders' Equity 125.81 66.73 9.04 11.10
Total Liabilities and Stockholders' Equity 135.20 76.44 14.60 14.07

Cash Flow Summary (Millions)

Categories 12/31/2017 6/30/2017 12/31/2016 12/31/2015
Net Cash Provided by Operating Activities -25.80 -5.70 -10.12 -9.71
Net Cash Provided by Investing Activities -0.17 -0.06 -0.31 -0.29
Net Cash Provided by Financing Activities 141.09 63.42 11.32 13.96

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20150.00-13.65--
12/20160.00-12.20--
12/20170.00-29.69-1.63
Growth RatesNaN----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/18228,22929.29




Report Date : 7/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.